AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached ...

The rise of long-term opioid therapy for chronic noncancer pain between 2013 and 2022 despite its limited effectiveness highlights the need for revised primary care pain guidelines. Between 2013 and ...

Pain and opioid use were reduced in patients with advanced knee OA following ultrasound-guided chemical neurolysis of 4 genicular nerves.

Chronic pain and PTSD are associated, with the pain varying as a function of the course of PTSD, suggesting a potential path for treatment planning.

The prevalence of frailty was 33% among a US-wide cohort of patients with RMDs, with the highest rates found among those with fibromyalgia or CTDs.

The Prognostic Nutritional Index and systemic oxidative stress score are independently associated with poorer prognosis of low-risk MDS.

Alopecia areata has a severe psychosocial impact, which is linked to illness perceptions and stigma more strongly than disease severity.

For older patients with cancer and T2D, GLP-1 RA use is associated with lower all-cause mortality than DPP4i use.

From 2010 to 2023, physician exit rates from traditional Medicare increased, according to study findings published in JAMA Health Forum.

Patients with chronic low back pain may exhibit worsened cognitive function compared with pain-free individuals.

Bedtime TNX-102 SL was safe and effective for the treatment of fibromyalgia by improving symptoms of pain, disrupted sleep, and fatigue.

Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.